PROVIDER PROFILE · NPI 1578543948
Richard Locicero
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
293
Beneficiaries
—
Total drug cost
$193K
Distinct drugs
16
Brand share
7.8%
Top prescribed drugs
Anastrozole47 claims
Letrozole44 claims
Quetiapine Fumarate23 claims
Haloperidol20 claims
Amlodipine Besylate19 claims
QUALITY · MIPS · 2024
Final MIPS score
89.1
Quality
87.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.59%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$32
Payment records
2
By payment type
Food and Beverage$32
Top paying entities
Food and Beverage$32
REFERRAL NETWORK
Where Richard Locicero's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 24 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| NORTHEAST GEORGIA MEDICAL CENTER, INC. | 294 | 3,235 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 110 | 545 |
| Scott Stephen Diagnostic Radiology · Gainesville, GA | 76 | 276 |
| Matthew Scott Diagnostic Radiology · Macon, GA | 56 | 235 |
| HOOPER, TREVOR | 40 | 280 |
| Anup Lahiry Hematology-Oncology · Flowery Branch, GA | 39 | 267 |
| Ajay Ravi Diagnostic Radiology · Gainesville, GA | 37 | 206 |
| Robert Balotin Diagnostic Radiology · Gainesville, GA | 28 | 135 |
| Lee Martin Diagnostic Radiology · Gainesville, GA | 28 | 149 |
| Julie Presley Diagnostic Radiology · Gainesville, GA | 27 | 113 |
| Timothy Carey Hematology-Oncology · Gainesville, GA | 26 | 171 |
| NASH, CHARLES | 23 | 154 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE